Status:
COMPLETED
Visual Field Defect Estimation Using Sequentially Optimized Reconstruction Strategy on Healthy and Glaucoma Subjects
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Collaborating Sponsors:
University of Bern
Conditions:
Glaucoma, Open-Angle
Eligibility:
All Genders
40-80 years
Brief Summary
Perimetry is a well-established method that is used to measure the visual field functions of humans. Commercially available products, such as the OCTOPUS 900 (Haag-Streit AG, Koeniz, Switzerland), are...
Eligibility Criteria
Inclusion
- Cataract yes or no
- Age range 40 - 80 years
- Normal visual field (MD: \< +2 dB)
- Refractive error within ±5 dpt. spherical equivalent
- Astigmatism of \< -3 dpt.
- Visual acuity of ≥0.3 logMar (decimal ≥0.5)
- Experience in perimetry (history of at least one perimetry examination)
- False positive or negative errors each less than 20% in each examination
- Primary open-angle/ pseudoexfoliation/ primary angle-closure glaucoma
- Early to moderate visual field loss (MD: +2 to +12 dB)
- Written informed consent
Exclusion
- Exclusion criteria are children (\<18 years old), inability to follow the procedure, insufficient knowledge of project language, the history of other ocular diseases than glaucoma or cataract or other conditions that might affect visual field testing (e.g. pituitary lesions, demyelinating diseases).
Key Trial Info
Start Date :
June 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
103 Patients enrolled
Trial Details
Trial ID
NCT03325751
Start Date
June 1 2018
End Date
November 1 2019
Last Update
January 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Inselspital, University Hospital Bern
Bern, Switzerland, 3010